
Jyong Biotech fell 94.3% from $30.72 to $1.76, behind the S&P 500's +13.3%. Its worst day was Dec 17 (−81.0%), and its low came Feb 11 at $1.46.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Jyong Biotech closed at its highest level of the year, 15.2% above where the year started.
+15.2% · S&P 500 +1.5%
Story events cover the past 12 months · Times ET
Jyong Biotech shares fell 81.0%, while the S&P 500 fell 1.1%.
−81.0%, the year's worst day · S&P 500 −1.1%
Jyong Biotech shares rose 51.8%, while the S&P 500 fell 0.1%.
+51.8%, the year's best day · S&P 500 −0.1%
Jyong Biotech closed at its lowest level of the year, 95.2% below where the year started.
−9.9% · S&P 500 0.0%
Jyong Biotech shares rose 35.8%, while the S&P 500 fell 1.0%.
+35.8% · S&P 500 −1.0%
EPS of $-0.06 was reported on $0.00 revenue.
−3.4% · S&P 500 −1.2%
Where it ended: a close of $1.76 on Nov 13, 2026. Up next: H1 2026 earnings on Nov 27, 2026.
Nothing in the past 12 months.
All MENS analyst actionsNothing in the past 12 months.
All MENS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MENS and SPY from Benzinga historical bars. Not investment advice.